Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-09-10
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514290, 514307, 546 17, 546101, 546110, 546141, 546146, 546321, 546322, A61K 3116, A61K 3117, C07D40110
Patent
active
055546218
ABSTRACT:
A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of nitrogen heterocyclic derivatives of 4-phenyl-1,4-dihydropyridines of Formula (I). ##STR1## As antagonists of NPY-induced feeding behavior, these compounds are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
REFERENCES:
patent: 4707486 (1987-11-01), Flockerzi et al.
patent: 4829076 (1989-05-01), Szil agyi et al.
Bruce Marc
Johnson Graham
LeBoulluec Karen
Noonan Jeffrey W.
Poindexter Graham S.
Bristol--Myers Squibb Company
Dahlen Garth M.
Ivy C. Warren
Ryan Richard P.
LandOfFree
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridine NPY antagonists: nitrogen heterocyclic derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridine NPY antagonists: nitrogen heterocyclic derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320694